FEMS Member Societies and Affiliated Organisations are organised according to the FEMS statutes. These societies and organisations may exert their rights, fulfil their duties, and claim their benefits as follows.
Member Societies are societies with a main or partial interest in microbiology, their delegates vote.
- Full Member: Full fee, eligible for benefits
- Provisional Member: Partial fee, they remain members for a limited acquainting period decided by Coucil then they must decide wether to take up full membership or not, eligible for benefits.
- Associate Member: Partial fee, partially for benefits
Affiliated Organisations are organisations such as enterprises, agencies, institutions. Their representatives can attend and speak at Council but cannot vote.
- Corresponding Member: Fee, partially eligible for benefits upon payment.
On this general basis the duties and rights are further specified below:
|Annual fees for Member Societies (Basis is
€1.40 per member of Member Society)
|Annual fee for Affiliated Organisations (basis is specific agreement with Corresponding Member)|
|Taking part in all activities||+||–|
|Research and Training Grants1||+||–|
|Meeting Organizer Grants1||+||–|
|Meeting Attendance Grants1||+||+|
|Journal Membership Subscription Price||+||+|
|Voting right at Council2||+||–|
|Attend and speak at Council||+||+|
|Taking part in Working Groups||+||–|
|Taking part in lobbying activities||+||–|
|Entry to website pages with restricted access||+||+|
|Promotion via website/Circular||+||–|
Note 1: benefit is lost when membership fees are more than two years in arrears (minute CO5-32/5.3)
Note 2: voting rights may be removed when membership fees are more than two years in arrears (article 23)
Two methods are described for efficient genetic modification of Saccharomyces cerevisiae using CRISPR/Cas9. The first method enables the modification of a single genetic locus using in vivo assembly of a guide RNA (gRNA) expression plasmid without the need for prior cloning. A second method using in vitro assembled plasmids that could contain up to two gRNAs was used to simultaneously introduce up to six genetic modifications (e.g. six gene deletions) in a single transformation step by transforming up to three gRNA expression plasmids simultaneously. The method is not only suitable for gene deletion but is also applicable for in vivo site-directed mutagenesis and integration of multiple DNA fragments in a single locus.